The conference will be attended by thousands of investors from around the world

*************** הכנס שיגיעו אליו אלפי משקיעים מהעולם – ואף לא מוסדי ישראלי כנס MIXII BIOMED הוא אחד הכנסים החשובים והמובילים בעולם בתחום מדעי החיים, שיוצגו בו טכנולוגיות עלית ישראליות בתחומים פורצי דרך – אבל את המוסדיים הישראליים זה כנראה לא מעניין 25/04/2017 בחודש מאי השנה ייערך בישראל כנס MIXII BIOMED ה-16 של ארגון הגג של […]

Patient centricity? Pharma’s there, expert says. It’s regulators who need to catch up

by Carly Helfand | Apr 17, 2017  Treato CEO Ido Hadari says patient centricity has become “a pillar in every life sciences and healthcare company out there.” YEHUD, ISRAEL—Compare pharma’s ideas about patient centricity today with their ideas a few years back, and “it would probably be like landing on different planets,” according to Ido […]

MeMed Wins $9.2M DTRA Contract for PoC IVD to Reduce Antibiotic Misuse

  Israeli firm MeMed won a contract worth up to $9.2 million from the U.S. Department of Defense (DoD) Defense Threat Reduction Agency (DTRA) to complete the development of a point-of-care in vitro diagnostic platform that can distinguish between bacterial and viral infections, and so help to prevent antibiotic misuse. MeMed’s diagnostic platform uses infection-specific […]

Mixiii Biomed 2017: Early Bird Registration

AN OPPORTUNITY NOT TO BE MISSED – TAKE AN ACTIVE ROLE REGISTER NOW (Early Bird Registration Deadline May 08, 2017) Dear Colleagues, Mixiii Biomed 2017 is generating great interest, with registration at its height. Ensure that you take advantage of the Early Bird Registration Fee (until 12:00 midnight May 8) and Register Now! For the 16th […]